481 related articles for article (PubMed ID: 24229823)
1. Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma.
Szefler SJ; Carlsson LG; Uryniak T; Baker JW
J Allergy Clin Immunol Pract; 2013 Jan; 1(1):58-64. PubMed ID: 24229823
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
[TBL] [Abstract][Full Text] [Related]
3. Montelukast vs. inhaled low-dose budesonide as monotherapy in the treatment of mild persistent asthma: a randomized double blind controlled trial.
Kumar V; Ramesh P; Lodha R; Pandey RM; Kabra SK
J Trop Pediatr; 2007 Oct; 53(5):325-30. PubMed ID: 17623754
[TBL] [Abstract][Full Text] [Related]
4. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
5. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy.
Maspero JF; Dueñas-Meza E; Volovitz B; Pinacho Daza C; Kosa L; Vrijens F; Leff JA
Curr Med Res Opin; 2001; 17(2):96-104. PubMed ID: 11759189
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
7. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
[TBL] [Abstract][Full Text] [Related]
8. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
Wahn U; Dass SB
Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
[TBL] [Abstract][Full Text] [Related]
9. The effect of montelukast and different doses of budesonide on IgE serum levels and clinical parameters in children with newly diagnosed asthma.
Stelmach I; Bobrowska-Korzeniowska M; Majak P; Stelmach W; Kuna P
Pulm Pharmacol Ther; 2005; 18(5):374-80. PubMed ID: 15939317
[TBL] [Abstract][Full Text] [Related]
10. Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.
Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Parasuraman B
Pediatrics; 2003 Sep; 112(3 Pt 1):e212-9. PubMed ID: 12949315
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness and safety of montelukast versus budesonide at various doses on bronchial reactivity in subjects with mild persistent asthma].
Riccioni G; D'Orazio N; Di Ilio C; Della Vecchia R; De Lorenzo A
Clin Ter; 2002; 153(5):317-21. PubMed ID: 12510415
[TBL] [Abstract][Full Text] [Related]
12. Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors.
Ducharme FM; Noya FJ; Allen-Ramey FC; Maiese EM; Gingras J; Blais L
Curr Med Res Opin; 2012 Jan; 28(1):111-9. PubMed ID: 22077107
[TBL] [Abstract][Full Text] [Related]
13. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
Rand C; Bilderback A; Schiller K; Edelman JM; Hustad CM; Zeiger RS;
J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
[TBL] [Abstract][Full Text] [Related]
14. Montelukast as an add-on therapy to inhaled corticosteroids in the treatment of severe asthma in elderly patients.
Bozek A; Warkocka-Szoltysek B; Filipowska-Gronska A; Jarzab J
J Asthma; 2012 Jun; 49(5):530-4. PubMed ID: 22551116
[TBL] [Abstract][Full Text] [Related]
15. Treatment of pediatric mild persistent asthma with low-dose budesonide inhalation suspension vs. montelukast in China.
Chen ZM; Zhao DY; Xiang L; Hong JG
World J Pediatr; 2021 Dec; 17(6):619-625. PubMed ID: 34613593
[TBL] [Abstract][Full Text] [Related]
16. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
Kopriva F; Dzubak P; Potesil J; Hajduch M
J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
[TBL] [Abstract][Full Text] [Related]
17. Spotlight on montelukast in asthma in children 2 to 14 years of age.
Muijsers RB; Noble S
Am J Respir Med; 2002; 1(3):225-8. PubMed ID: 14720060
[TBL] [Abstract][Full Text] [Related]
18. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma.
Bisgaard H; Zielen S; Garcia-Garcia ML; Johnston SL; Gilles L; Menten J; Tozzi CA; Polos P
Am J Respir Crit Care Med; 2005 Feb; 171(4):315-22. PubMed ID: 15542792
[TBL] [Abstract][Full Text] [Related]
19. Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide.
Miraglia del Giudice M; Piacentini GL; Capasso M; Capristo C; Maiello N; Boner AL; Capristo AF
Respir Med; 2007 Aug; 101(8):1809-13. PubMed ID: 17418554
[TBL] [Abstract][Full Text] [Related]
20. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
Zeiger RS; Bird SR; Kaplan MS; Schatz M; Pearlman DS; Orav EJ; Hustad CM; Edelman JM
Am J Med; 2005 Jun; 118(6):649-57. PubMed ID: 15922697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
